Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 27.5B | 25.2B | 24.1B | 22.3B |
| Cost of revenue | 19.3B | 17.6B | 17.0B | 15.3B |
| Gross profit | 8.2B | 7.5B | 7.1B | 7.0B |
| Operating expense | ||||
| Research & development | — | — | — | — |
| Selling general and admin | — | — | — | — |
| Other operating expenses | 3.0B | 2.7B | 2.7B | 2.3B |
| Operating income | 3.2B | 3.0B | 2.7B | 3.0B |
| Non operating interest income | ||||
| Income | — | — | — | — |
| Expense | 27.5M | 13.8M | 24.1M | 5.5M |
| Other income expense | — | — | — | — |
| Pretax income | 3.8B | 3.3B | 2.9B | 3.4B |
| Tax provision | 1.1B | 970.1M | 741.7M | 944.3M |
| Net income | 2.7B | 2.4B | 2.2B | 2.4B |
| Basic EPS | — | 1.6 | 1.5 | 1.6 |
| Diluted EPS | — | 1.6 | 1.4 | 1.6 |
| Basic average shares | — | 1.5B | 1.5B | 1.5B |
| Diluted average shares | — | 1.5B | 1.5B | 1.5B |
| EBITDA | 4.2B | 3.6B | 3.2B | 3.6B |
| Net income from continuing op. | — | — | — | — |
| Minority interests | -22.9M | 26.8M | 13.3M | -1M |
| Preferred stock dividends | 0 | 0 | 0 | 0 |